Primis Financial (NASDAQ:FRST) said on Tuesday that the regional lender expects an after-tax gain of ~$20.0M, or $0.81 per ...

today reported financial results for the quarter ended March 31, 2025, and provided a corporate update. “The first quarter of 2025 marked yet another exciting milestone for Gain with the first ...

Shares of banks and other financial institutions rose as a rebound in global equity markets gained steam. By one measure, the S&P 500 was set to re-enter bull market territory, rising by almost 20% ...

Shares of banks and other financial institutions rose amid hopes for continued calm in global markets. One observer said another bout of volatility is highly possible, given the uncertain situation ...

Gain Therapeutics reports Q1 2025 financial results, progressing Phase 1b study of Parkinson's treatment GT-02287, with FDA engagement anticipated. Successful administration of GT-02287 ...

powerful tips to help you turn that refund into long-term financial gain — from debt reduction to strategic investing and everything in between. Watch the video player for the full interview.

With the stock's current price at Rs 437.15, ITC has demonstrated a slight gain in today's trading session, marking its presence in the NIFTY 50 index.

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS ...